Effect of potassium and tris-aspartate on heparin-induced serum free-fatty-acids evaluation, in man.
D000368:Aged; D001161:Arteriosclerosis / Q000097:blood; D001224:Aspartic Acid / Q000627:therapeutic use*; D001786:Blood Glucose; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000188:drug therapy*; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000097:blood; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000627:therapeutic use*; D013312:Stress, Physiological / Q000188:drug therapy
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D001224:Aspartic Acid; D006493:Heparin; D002784:Cholesterol; D011188:Potassium